Suchergebnisse - "Willingham, Stephen B"

PubPharm (48)

1

Clinical Results with a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19

enthalten in: bioRxiv.org | 2023

von Miller, R. | Guru, P. | Bauer, P. | +16

2

Anti-CD73 antibody activates human B cells, enhances humoral responses and induces redistribution of B cells in patients with cancer

enthalten in: Journal for immunotherapy of cancer | 2022

von Miller, R. | Luke, J. | Hu, S. | +6

3

Characterization and Phase 1 Trial of a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19

enthalten in: bioRxiv.org | 2021

von Willingham, S. | Criner, G. | Hill, C. | +14

4

Targeting the A2AR in cancer; early lessons from the clinic

enthalten in: Current opinion in pharmacology | 2020

von Willingham, S. | Hotson, A. | Miller, R.

5

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

enthalten in: Cancer discovery | 2020

von Fong, L. | Hotson, A. | Powderly, J. | +30

CommentIn: Cancer Discov. 2020 Jan;10(1):16-19. - PMID 31919119

6

Therapeutic blockade of CXCR2 rapidly clears inflammation in arthritis and atopic dermatitis models : demonstration with surrogate and humanized antibodies

enthalten in: mAbs | 2020

von Alam, M. | Xie, L. | Ang, C. | +6

7

Dysregulated integrin αVβ3 and CD47 signaling promotes joint inflammation, cartilage breakdown, and progression of osteoarthritis

enthalten in: JCI insight | 2019

von Wang, Q. | Onuma, K. | Liu, C. | +21

8

A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti-PD-(L)1 and Anti-CTLA-4 in Preclinical Models

enthalten in: Cancer immunology research | 2018

von Willingham, S. | Ho, P. | Hotson, A. | +7

9

A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer

enthalten in: Nature communications | 2017

von Betancur, P. | Abraham, B. | Yiu, Y. | +15

CommentIn: J Thorac Dis. 2017 Aug;9(8):2279-2282. - PMID 28932524

10

Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2016

von Krampitz, G. | George, B. | Willingham, S. | +16

CommentIn: Nat Rev Gastroenterol Hepatol. 2016 Jun;13(6):314-5. - PMID 27095652

1
2
3
4
5
Nächster »
[5]